Abstract
Introduction: Folic acid is considered an key molecule during fetal brain development. There have been potential benefits of this intervention during pregnancy such as reducing the risk of autism spectrum disorders. Objective: To analyze the evidence of folic acid in the periconceptional period for the prevention of autism spectrum disorders through a literature review. Materials and methods: A search of scientific articles was conducted in PubMed data base and Clinical Trials during the months of August 2014 to March 2015. The MeSH terms used were “folic acid”, “autism” and “pregnancy”. Review and original articles in English and Spanish are included, regardless of date of publication. Results: Four observational studies were found where the association is evaluated: two case-control, one cohort and one ecological study. Contradictory results are described, associated with the methodology of the studies. Methylation defects corrected with supplementation of folic acid could explain the potential benefit in preventing autism spectrum disorders. Conclusions: The evidence limited and inconsistent establishing that the intake of folic acid during the periconceptional period constitutes a protective factor for the development of autism spectrum disorders. MÉD UIS. 2015;28(3):327-36.
Keywords: Folic acid. Autistic Disorder. Pregnancy. Primary Prevention.
References
Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA.1993;269(10):1257-61.
Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, et al. Prevention of neural-tube defects with folic acid in China. ChinaU.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999;341(20):1485-90.
Song S, Wang W, Hu P. Famine, death, and madness: schizophrenia in early adulthood after prenatal exposure to the Chinese Great Leap Forward Famine. Soc Sci Med. 2009;68(7):1315-21.
Roth C, Magnus P, Schjolberg S, Stoltenberg C, Suren P, McKeague IW, et al. Folic acid supplements in pregnancy and severe language delay in children. JAMA. 2011;306(14):1566-73.
Catov JM, Bodnar LM, Ness RB, Markovic N, Roberts JM. Association of periconceptional multivitamin use and risk of preterm or small-for-gestational-age births. Am J Epidemiol. 2007;166(3):296-303.
Catov JM, Nohr EA, Bodnar LM, Knudson VK, Olsen SF, Olsen J. Association of periconceptional multivitamin use with reduced risk of preeclampsia among normal-weight women in the Danish National Birth Cohort. Am J Epidemiol. 2009;169(11):1304-11.
Institute of Medicine. Nutrition During Pregnancy: Part I Weight Gain: Part II Nutrient Supplements. Washington (DC)1990.
Picciano MF. Pregnancy and lactation: physiological adjustments, nutritional requirements and the role of dietary supplements. J Nutr. 2003;133(6):1997S-2002S.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition (DSM-4). 2000.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition (DSM-5). 2013.
Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry. 2005;66(Suppl 10):3-8.
Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ. 2007;56(1):12-28.
Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 2009;58(10):1-20.
Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. 2009;65(6):591-8.
Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ.
;61(3):1-19.
Williams JG, Higgins JP, Brayne CE. Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child. 2006;91(1):8-15.
Lejarraga H, Menendez AM, Menzano E, Guerra L, Biancato S, Pianelli P, et al. Screening for developmental problems at primary care level: a field programme in San Isidro, Argentina. Paediatr Perinat Epidemiol. 2008;22(2):180-7.
Montiel-Nava C, Peña JA. Epidemiological findings of pervasive developmental disorders in a Venezuelan study. Autism. 2008;12(2):191-202.
Paula CS, Ribeiro SH, Fombonne E, Mercadante MT. Brief report: prevalence of pervasive developmental disorder in Brazil: a pilot study. J Autism Dev Disord. 2011;41(12):1738-42.
Talero-Gutiérrez C, Rodríguez M, De La Rosa D, Morales G, Vélez-Van-Meerbeke A. Profile of children and adolescents with autism spectrum disorders in an institution in Bogota, Colombia. Neurologia. 2012;27(2):90-6.
Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum disorders. Pediatrics. 2007;120(5):1183-215.
Pickett J, London E. The neuropathology of autism: a review. J Neuropathol Exp Neurol. 2005;64(11):925-35.
Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics. 004;113(5):e472-86.
Cohen D, Pichard N, Tordjman S, Baumann C, Burglen L, Excoffier E, et al. Specific genetic disorders and autism: clinical contribution towards their identification. J Autism Dev Disord. 2005;35(1):103-16.
Grafodatskaya D, Chung B, Szatmari P, Weksberg R. Autism spectrum disorders and epigenetics. J Am Acad Child Adolesc Psychiatry. 2010;49(8):794-809.
Ozonoff S, Young GS, Carter A, Messinger D, Yirmiya N, Zwaigenbaum L, et al. Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics. 2011;128(3):e488-95.
Rosenfeld CS. Animal models to study environmental epigenetics. Biol Reprod. 2010;82(3):473-88.
Albertini DF. Folate forever-- all methyl group donationswelcome!. J Assist Reprod Genet. 2013;30(5):607-8.
Deth R, Muratore C, Benzecry J, Power-Charnitsky VA, Waly M. How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis. Neurotoxicology. 2008;29(1):190-201.
Calderon J, Navarro ME, Jimenez-Capdeville ME, Santos-Diaz MA, Golden A, Rodriguez-Leyva I, et al. Exposure to arsenic and lead and neuropsychological development in Mexican children. Environ Res. 2001;85(2):69-76.
Wright RO, Amarasiriwardena C, Woolf AD, Jim R, Bellinger DC. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology. 2006;27(2):210-6.
Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002;347(19):1477-82.
Wilson K, Mills E, Ross C, McGowan J, Jadad A. Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine: a systematic review of current epidemiological evidence. Arch Pediatr Adolesc Med. 2003;157(7):628-34.
Schultz ST. Does thimerosal or other mercury exposure increase the risk for autism? A review of current literature. Acta Neurobiol Exp (Wars). 2010;70(2):187-95.
Harari R, Julvez J, Murata K, Barr D, Bellinger DC, Debes F, et l.Neurobehavioral deficits and increased blood pressure in schoolage children prenatally exposed to pesticides. Environ Health Perspect. 2010;118(6):890-6.
Lee BK, Gardner RM, Dal H, Svensson A, Galanti MR, Rai D, et al. Brief report: maternal smoking during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2012;42(9):2000-5.
Tran PL, Lehti V, Lampi KM, Helenius H, Suominen A, Gissler M, et al. Smoking during pregnancy and risk of autism spectrum disorder in a Finnish National Birth Cohort. Paediatr Perinat Epidemiol. 2013;27(3):266-74.
Eliasen M, Tolstrup JS, Nybo Andersen AM, Gronbaek M, Olsen J, Strandberg-Larsen K. Prenatal alcohol exposure and autistic spectrum disorders-a population-based prospective study of 80,552 children and their mothers. Int J Epidemiol.
;39(4):1074-81.
Schmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL, Hartiala J, Allayee H, et al. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr. 2012;96(1):80-9.
Ramaekers VT, Blau N, Sequeira JM, Nassogne MC, Quadros EV. Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. Neuropediatrics. 2007;38(6):276-81.
James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, et al. Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr. 2009;89(1):425-30.
Suren P, Roth C, Bresnahan M, Haugen M, Hornig M, Hirtz D, et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA. 2013;309(6):570-7.
Stoltenberg C, Schjolberg S, Bresnahan M, Hornig M, Hirtz D, Dahl C, et al. The autism birth cohort: a paradigm for gene-environmenttiming research. Mol Psychiatry. 2010;15(7):676-80.
Suren P, Bakken IJ, Aase H, Chin R, Gunnes N, Lie KK, et al. Autism spectrum disorder, ADHD, epilepsy, and cerebral palsy in Norwegian children. Pediatrics. 2012;130(1):152-8.
Crider KS, Bailey LB, Berry RJ. Folic acid food fortificationits history, effect, concerns, and future directions. Nutrients. 2011;3(3):370-84.
Leeming RL, M. Autism: is there a folate connection ?. J Inherit Metab Dis. 2009;32(3):400-2.
Rogers EJ. Has enhanced folate status during pregnancy altered natural selection and possibly autism prevalence ? A closer lookat a possible link. Med Hypotheses. 2008;71(3):406-10.
Leeming RJ, Blair JA, Melikian V, O’Gorman DJ. Biopterin derivatives in human body fluids and tissues. J Clin Pathol. 1976;29(5):444-51.
Ramaekers VT, Hausler M, Opladen T, Heimann G, Blau N. Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Neuropediatrics. 2002;33(6):301-8.
Beard CM, Panser LA, Katusic SK. Is excess folic acid supplementation a risk factor for autism ?. Med Hypotheses. 2011;77(1):15-7.
Al-Farsi YM, Waly MI, Deth RC, Al-Sharbati MM, Al-Shafaee M, Al-Farsi O, et al. Low folate and vitamin B12 nourishment is common in Omani children with newly diagnosed autism. Nutrition. 2013;29(3):537-41.
Menezo Y, Mares P, Cohen M, Brack M, Viville S, Elder K. Autism, imprinting and epigenetic disorders: a metabolic syndrome linked to anomalies in homocysteine recycling starting in early life ?. J Assist Reprod Genet. 2011;28(12):1143-5.
Currenti SA. Understanding and determining the etiology of autism. Cell Mol Neurobiol. 2010;30(2):161-71.
Lv J, Xin Y, Zhou W, Qiu Z. The epigenetic switches for neural development and psychiatric disorders. J Genet Genomics. 2013;40(7):339-46. Epub 2013 May 9.
Guo T, Chen H, Liu B, Ji W, Yang C. Methylenetetrahydrofolate reductase polymorphisms C677T and risk of autism in the Chinese Han population. Genet Test Mol Biomarkers. 2012;16(8):968-73. Epub 2012 Jul 9.
Pu D, Shen Y, Wu J. Association between MTHFR Gene Polymorphisms and the Risk of Autism Spectrum Disorders: A Meta-Analysis. Autism Res. 2013;6(5):384-92. Epub 2013 May 7.
Schanen NC. Epigenetics of autism spectrum disorders. Hum Mol Genet. 2006;15 Spec No 2:R138-50.
Gregory SG, Connelly JJ, Towers AJ, Johnson J, Biscocho D, Markunas CA, et al. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med. 2009;7:62.
LaSalle JM. A genomic point-of-view on environmental factors influencing the human brain methylome. Epigenetics. 2011;6(7):862-9. Epub 2011 Jul 1.
Frustaci A, Neri M, Cesario A, Adams JB, Domenici E, Dalla Bernardina B, et al. Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med. 2012;52(10):2128-41. Epub 2012 Apr 18.
Castro K, Klein LD, Baronio D, Gottfried C, Riesgo R, Perry IS. Folic acid and autism: What do we know? Nutr Neurosci. 2014.
Rodier PM, Ingram JL, Tisdale B, Nelson S, Romano J. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol. 1996;370(2):247-61.
Froster-Iskenius U, Bödeker K, Oepen T, Matthes R, Piper U, Schwinger E. Folic acid treatment in males and females with fragile-(X)-syndrome. Am J Med Genet. 1986;23(1-2):273-89.
Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child
Neurol. 2004;46(12):843-51.
Linet M. Follow-up Study of Late Effects of Periconceptional FolicAcid in Mothers and Offspring in the Community Intervention Program Population: The Chinese Children and Families Study. 2011 [updated 2013/05/23]. Available from: http://clinicaltrials. gov/show/NCT01365975Program Population: The Chinese
Children and Families Study. 2011 [updated 2013/05/23]. Available from: http://clinicaltrials.gov/show/NCT01365975.